Next Article in Journal
Magnetic Resonance-Guided High-Intensity Focused Ultrasound Ablation of Uterine Fibroids—Efficiency Assessment with the Use of Dynamic Contrast-Enhanced Magnetic Resonance Imaging and the Potential Role of the Administration of Uterotonic Drugs
Next Article in Special Issue
The Diagnosis of Perineural Invasion: A Crucial Factor in Novel Algorithm of Coexistence of Conventional and Nerve-Sparing Radical Hysterectomy
Previous Article in Journal
An Emerging Anti-p16 Antibody-BC42 Clone as an Alternative to the Current E6H4 for Use in the Female Genital Tract Pathological Diagnosis: Our Experience and a Review on p16ink4a Functional Significance, Role in Daily-Practice Diagnosis, Prognostic Potential, and Technical Pitfalls
Previous Article in Special Issue
Multicentre Evaluation of Hepika Test Clinical Accuracy in Diagnosing HPV-Induced Cancer and Precancerous Lesions of the Uterine Cervix
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Diagnostics
Volume 11
Issue 4
10.3390/diagnostics11040714
Review Report
diagnostics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Article
Peer-Review Record

Pretreatment [18F]FDG PET/CT Prognostic Factors in Patients with Squamous Cell Cervical Carcinoma FIGO IIIC1

Diagnostics 2021, 11(4), 714; https://doi.org/10.3390/diagnostics11040714
by Ewa Burchardt 1,2,*, Wojciech Burchardt 2,3, Paulina Cegła 4, Anna Kubiak 5, Andrzej Roszak 1,2 and Witold Cholewiński 2,4
Reviewer 1:
Qiu Jiantai Timothy
Reviewer 2: Anonymous
Diagnostics 2021, 11(4), 714; https://doi.org/10.3390/diagnostics11040714
Submission received: 15 February 2021 / Revised: 12 April 2021 / Accepted: 14 April 2021 / Published: 16 April 2021
(This article belongs to the Special Issue Cervical Cancer Screening, Management, and Prevention)

Round 1

Reviewer 1 Report

Should invite Gyn. Oncologists to join in and listed as co-authors. Because 3-years and 5-years OS data were influenced by their salvage treatment.

FIGO 2018 staging also apply pathological staging. Can you incorporate this into your manuscript?

PET   SUV uptake was influenced by patient's renal function which should be addressed.

Author Response

 "Please see the attachment."

Author Response File: Author Response.docx

Reviewer 2 Report

Line 45 : typo on disease

Line 93 : SUV not spelled at first occurrence, AUC/SCH not spelled

IRB approval not specified

Table 1 2 typos on Length of hospitalization

Table 2 might be complemented by the corresponding figures in patients free of disease vs patients who recurrent

Line 189 DFMS not spelled

Line 191 sentence should be rephrased as : “No differences were observed”

Line 198 : important should be replaced by significant

Lines  231-232     duplicate the legend of figure, should be replaced by a call to figures 5 and 6

Line 234 : full, not fully

Line 236 : cervical cervix, please fix

Line 272 : has, not had

Line 281 : study, not studies

Line 282 : not significant instead of insignificant

Lines 285, 287, 288 : “he” refers to Hong et al., hence “they” should be used ; in addition, the argumentation in the whole paragraph is difficult to understand and should be rewritten

Line 291 : Sentence is awkward

Conclusion is a summary of results. Should feature a statement on the clinical utility of the finding : adaptation of treatment ? closer follow up ?

 

 

 

 

Author Response

The text has been corrected as suggested. "Please see the attachment- Track Changes"."

IRB approval not specified: Decision attached, described below the manuscript

Table 2 might be complemented by the corresponding figures in patients free of disease vs patients who recurrent. Tables attached to manuscript.

 

Author Response File: Author Response.docx

Back to TopTop